why choose us

First received: March 07, 2023

Clinical Trial: LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media

Study Status: Completed

Recruit Status: RECRUITING

Condition: Upper Respiratory Tract Infections

Study Type: INTERVENTIONAL


Official Title: Application of LiveSpo Navax® in the Treatment Support of Acute Rhinosinusitis and Acute Otitis Media

Brief Summary: Acute respiratory tract infections (ARTIs), such as acute rhinosinusitis (ARS) and acute otitis media (AOM), are common worldwide and caused by viruses or bacteria entering the body through the mouth and nose.AOM frequently occurs in young children and is caused by bacterial reflux into the middle ear.ARS is a relatively common ARTIs and can occur at many ages.To accurately diagnose disease, careful clinical examination and accurate clinical judgment are required, as making a reasonable treatment regimen with the…

Read more